• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    Idera Pharmaceuticals, Inc. (IDRA)

    -NasdaqCM
    4.87 Down 0.27(5.25%) Feb 27, 4:00PM EST
    Add to Portfolio
    Prev Close:5.14
    Open:5.15
    Bid:3.13 x 600
    Ask:5.20 x 200
    1y Target Est:7.00
    Beta:2.64
    Next Earnings Date:N/A
    Day's Range:4.87 - 5.18
    52wk Range:1.94 - 6.87
    Volume:4,556,764
    Avg Vol (3m):2,457,020
    Market Cap:417.89M
    P/E (ttm):N/A
    EPS (ttm):-0.44
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for IDRA

    Comparison

    Symbol% ChgMkt Cap
    IDRADown 5.25%417.89M
    DVAXUp 0.57%462.76M
    PFEDown 0.78%216.24B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):5,880.85
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.45
    Quarterly EPS Est (Dec-14) :-0.11
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Idera Pharmaceuticals, Inc., a clinical stage biotechnology company, is engaged in the discovery and development of novel therapeutics that modulate immune responses through toll-like receptors (TLRs) in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback